James A. Edwards

Array ( [id] => 10353601 [patent_doc_number] => 20150238606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING LULICONAZOLE' [patent_app_type] => utility [patent_app_number] => 14/427890 [patent_app_country] => US [patent_app_date] => 2013-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7660 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9971369 [patent_doc_number] => 09018380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Heterocyclic modulators of HIF activity for treatment of disease' [patent_app_type] => utility [patent_app_number] => 13/974258 [patent_app_country] => US [patent_app_date] => 2013-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 58336 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13974258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12364125 [patent_doc_number] => 09956235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-01 [patent_title] => Reducing the reproductive capacity of mammals [patent_app_type] => utility [patent_app_number] => 14/423245 [patent_app_country] => US [patent_app_date] => 2013-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 22 [patent_no_of_words] => 5511 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10864181 [patent_doc_number] => 08889882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'Process for preparing biphenyl imidazole compounds' [patent_app_type] => utility [patent_app_number] => 13/973171 [patent_app_country] => US [patent_app_date] => 2013-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10396 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13973171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15751201 [patent_doc_number] => 10617683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-14 [patent_title] => Inhibitors of CRL4 ubiquitin ligase and uses thereof [patent_app_type] => utility [patent_app_number] => 14/422571 [patent_app_country] => US [patent_app_date] => 2013-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 11 [patent_no_of_words] => 7523 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9199060 [patent_doc_number] => 20130338375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'Thioamide Compound, Method for Producing Thioamide Compound, Method for Producing [(4R,6R)-6-Aminoethyl-1,3-Dioxan-4-YL]Acetate Derivative, and Method for Producing Atorvastatin' [patent_app_type] => utility [patent_app_number] => 13/971186 [patent_app_country] => US [patent_app_date] => 2013-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14813 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13971186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10241573 [patent_doc_number] => 20150126568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF HYPERTENSION AND MANAGEMENT OF DIABETIC KIDNEY DISEASE' [patent_app_type] => utility [patent_app_number] => 14/399529 [patent_app_country] => US [patent_app_date] => 2013-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10339 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10365689 [patent_doc_number] => 20150250694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'BLENDS OF O-ACYL-ISETHIONATES AND N-ACYL AMINO ACID SURFACTANTS' [patent_app_type] => utility [patent_app_number] => 14/435267 [patent_app_country] => US [patent_app_date] => 2013-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9851 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10339080 [patent_doc_number] => 20150224086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'Pharmaceutical Formulations of Rufinamide' [patent_app_type] => utility [patent_app_number] => 14/422884 [patent_app_country] => US [patent_app_date] => 2013-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2488 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9263342 [patent_doc_number] => 20130345271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'POLYMORPHIC, CRYSTALLINE AND MESOPHASE FORMS OF SODIUM 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO) ACETATE, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/954736 [patent_app_country] => US [patent_app_date] => 2013-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19514 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13954736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10274087 [patent_doc_number] => 20150159084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/414844 [patent_app_country] => US [patent_app_date] => 2013-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7818 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10147852 [patent_doc_number] => 09180116 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions' [patent_app_type] => utility [patent_app_number] => 14/415506 [patent_app_country] => US [patent_app_date] => 2013-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 63536 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14415506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307237 [patent_doc_number] => 20140045911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'Phenoxy-Pyrrolidine Derivative and Its Use and Compositions' [patent_app_type] => utility [patent_app_number] => 13/945622 [patent_app_country] => US [patent_app_date] => 2013-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9595 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13945622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10305357 [patent_doc_number] => 20150190357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-09 [patent_title] => 'USE OF A CREAM THAT PROTECTS AGAINST THE EFFECTS OF AGGRESSIVE CHEMICAL AGENTS IN CONTACT WITH THE SKIN' [patent_app_type] => utility [patent_app_number] => 14/415428 [patent_app_country] => US [patent_app_date] => 2013-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5421 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14415428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977706 [patent_doc_number] => 09024017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Octahydro-cyclopentapyrrolyl antagonists of CCR2' [patent_app_type] => utility [patent_app_number] => 13/943099 [patent_app_country] => US [patent_app_date] => 2013-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37176 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13943099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9775417 [patent_doc_number] => RE045183 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2014-10-07 [patent_title] => 'Heteroaryl-ureas and their use as glucokinase activators' [patent_app_type] => reissue [patent_app_number] => 13/940786 [patent_app_country] => US [patent_app_date] => 2013-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85441 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13940786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273636 [patent_doc_number] => 08637568 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Serotonin reuptake inhibitors' [patent_app_type] => utility [patent_app_number] => 13/936312 [patent_app_country] => US [patent_app_date] => 2013-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22218 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13936312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10437086 [patent_doc_number] => 20150322099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-12 [patent_title] => 'THERAPEUTIC BISPHOSPHONATES' [patent_app_type] => utility [patent_app_number] => 14/412578 [patent_app_country] => US [patent_app_date] => 2013-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19524 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 46 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9212838 [patent_doc_number] => 20140012015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'PROCESS FOR PREPARING BICYCLIC AMINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/933961 [patent_app_country] => US [patent_app_date] => 2013-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27933 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13933961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10290538 [patent_doc_number] => 20150175537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'NOVEL PYRROLIDINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/412050 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12968 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412050 [rel_patent_id] =>[rel_patent_doc_number] =>)